In this video from the 1st NCRI AML academy meeting, Professor Charles Craddock, Queen Elizabeth Hospital, Birmingham, UK, introduces the David Grimwade Memorial Lecture, given by Professor Gert Ossenkoppele.
Professor Craddock pays homage to his colleague and friend, David Grimwade, who passed away in October 2016, by detailing his commitment to the field of hematology, his passion for patient care and his fun nature. David Grimwade was at the forefront of research into the pathogenesis of acute promyelocytic leukemia (APL) and pioneered the application of measurable residual disease (MRD) management into clinical practice. He was also one of the first to extend this to acute myeloid leukemia (AML) and stem cell transplantation. His belief of tailoring therapy in AML had a global impact and provided a prime example that advances in basic science could rapidly be applied to clinical practice.
Professor Craddock pays tribute to David's fun nature with anecdotal stories of their congress travel together and highlights how David's interactions between the laboratory and the clinic, attention to detail, infectious spirit of enquiry and academic collaboration should inspire us to work together to transform patient care.